Clinical Trial Search

Primary: Event Rate of All-Cause Mortality, Myocardial Infarction (MI), or Stroke — 13.44; 14.27 Event rate per 100 patient-year — p=0.270

Primary: Change in Mullen Scales of Early Learning - Expressive Language Raw Score — 19.69; 18.19; 21.81; 20.31 score on a scale

Primary: Change in Average Morning Fasting Free Testosterone Blood Concentrations From Baseline — 0.91; 1.03 nmol/L — p=0.353

Primary: Change in Clinician-Reported Submental Fat Rating Scale — 5; 4; 5; 6 Participants

Primary: Change in Mu-opioid Receptor Binding Potential (BP) Between Baseline and Post-patch Scans — -2.47; -5.94; 5.60; -1.24 ratio

Primary: Chest CT (High Resolution Computed Tomography (HRCT) Score) — 3.7; 6.1 Score points

Primary: Percent Change in Glycosylated Hemoglobin A1c (HbA1c) From Baseline to Week 12 — 0.0005; 0.0029; 0.0007; 0.0004 Percent Change

Primary: Change in Lumbar Spine Bone Mineral Density (LS-BMD) on Active Medication — 10.1; 4.1 percentage of change

Primary: Efficacy of Patiromer in Reducing Serum Potassium — 6.17; 6.6; 5.9; 6.47 mEq/L

Primary: Number of Participants With Clinically Significant Prostate Cancer — 6; 6 Participants

Primary: Percentage of Participants With Detection of at Least One Adenoma Per Procedure — 63.7; 68.1 percentage of participants

Primary: Change in C-reactive Protein — 6.4; 2.7; 2.9; 5.9 ng/mL — p=0.038

Primary: Blood Inflammatory Marker — 2.6; 1.8; 2.9; 1.7 mg·L^-1

Primary: Percentage of Participants Who Had One or More Adverse Events — 10.54 Percentage of Participants

Primary: Assess Parents' Knowledge Regarding Their Child's Risk for a Significant Brain Injury — 6.2; 5.26 Number of questions correct out of 10